Precision Spine Launches Nationally the SureLOK MIS 3L Percutaneous Screw System

Offering Surgeons Outstanding Versatility and Flexibility

The SureLOK MIS 3L Percutaneous Screw System, which provides spine surgeons with outstanding versatility and flexibility in terms of procedural approaches and application of its various components.

“The inherent versatility of the SureLOK MIS 3L System enables it to be used in Open, Mini-Open or Percutaneous MIS approaches, or even a combination of any of those approaches during the same procedure,” said Phillip Kravetz, MD, who worked with the Precision Spine design team in the development of the system. “This flexibility provides surgeons with a range of options intended to optimize efficiency and effectiveness in both planning and performing successful spinal procedures.”

“The SureLOK MIS 3L Percutaneous Screw System represents another example of how Precision Spine is making good on its commitment to develop minimally invasive devices that feature the versatility and flexibility surgeons need to help improve OR efficiency and achieve positive patient outcomes,” said Chris DeNicola, Chief Operating Officer of Precision Spine.

Component versatility is another key element of the SureLOK MIS 3L System, which consists of cannulated pedicle screws, straight and pre-curved rods, and locking caps, all of which are available in a variety of sizes that enable surgeons to more closely match each patient’s anatomy. The screws feature a 150mm Extended Tab designed to allow for low profile, MIS Percutaneous placement with 50mm of controlled rod reduction. In addition, an Open Tulip design helps ease rod introduction while the proximal tapered triple lead thread helps enhance efficiency in placing screws and optimize pull-out strength. The screw’s self-tapping tip is designed to help ease insertion and a square thread locking cap assists in reducing the potential for cross threading. The system’s easy-to-use percutaneous rod inserter features a bulleted tip, keyed hex end and 15° rod angle which helps ease rod insertion and release; the inserter shaft is designed to glide easily through the tulips for fast and efficient rod delivery. The system also includes a reliable compression/distraction system.

The indications of the SureLOK MIS 3L System provide further versatility. The system can be used in the immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of acute and chronic instabilities or deformities of the thoracic, lumbar and sacral spine. It may also be used for non-cervical pedicle screw fixation for severe spondylolisthesis, trauma, spinal stenosis, curvatures, spinal tumor, pseudarthrosis and failed previous fusion.

“The SureLOK MIS 3L Percutaneous Screw System represents another example of how Precision Spine is making good on its commitment to develop minimally invasive devices that feature the versatility and flexibility surgeons need to help improve OR efficiency and achieve positive patient outcomes,” said Chris DeNicola, Chief Operating Officer of Precision Spine.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.